Detalles de la búsqueda
1.
Design of new potent and selective secretory phospholipase A(2) inhibitors. 6-Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives.
Bioorg Med Chem
; 18(10): 3588-600, 2010 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20417107
2.
Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.
J Med Chem
; 50(7): 1618-26, 2007 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-17335183
3.
Evaluation of iron oxide nanoparticle biocompatibility.
Int J Nanomedicine
; 6: 787-94, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21589646
4.
Synthesis and evaluation of 5-Aryl-3-(4-hydroxyphenyl)-1,3,4-oxadiazole-2-(3H)-thiones as P-glycoprotein inhibitors.
Chem Pharm Bull (Tokyo)
; 51(6): 728-30, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12808255
5.
Novel routes to chiral 2-alkoxy-5-/6- methoxycarbonylmethylidenepyrrolidines/-piperidines.
J Org Chem
; 69(8): 2888-91, 2004 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-15074948
Resultados
1 -
5
de 5
1
Próxima >
>>